test already available on the market for early and precise diagnoses

69

A new examination of blood could revolutionize the early diagnosis of the disease Alzheimer, allowing it to be identified well before symptoms appear. The test, already available on the market, measures the levels of p-tau 217 protein (biomarker for early Alzheimer’s disease) and, according to the authors of a study published in Jama Neurology, could be used to screen for the disease in the over-age population. 50.

Alzheimer’s, here are the first symptoms